COMPANY

Biotia

HQ: Long Island City, NY source · biotia.io ↗ · Mid-Atlantic

Biotia is a health tech company advancing infectious disease diagnostics for challenging infections. From company website Source · checked 2026-10-19

Sources for this description (1)

Biotia is a health tech company advancing infectious disease diagnostics for challenging infections.
- “Biotia is a health tech company advancing infectious disease diagnostics for challenging infections.” https://biotia.io/about (2026-10-19)

Keywords: diagnostics infectious disease

Location: Long Island City, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Undisclosed round · $9M · announced Oct 1, 2026 Company release ↗
Source quote
- Oct 1, 2026 · Company release ↗
  “New York, NY – October 1, 2026 — Biotia , the clinical metagenomics company whose BIOTIA-ID Urine Test identifies the cause of recurrent and complicated urinary tract infections (UTIs) with 97% sensitivity and 99% specificity, today announced an oversubscribed $9 million financing”

Raises announced in these releases: $9M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Oct 1, 2026 Raise Private equity round: $9M (total, as published), announced Oct 1, 2026. Source: company's own press page. source ↗
Oct 1, 2026 Raise Undisclosed round · $9M source ↗
Sep 2, 2025 Partnership Partnership / licensing announced Sep 2, 2025. Source: company's own press page. source ↗
Apr 2, 2025 Partnership Partnership / licensing announced Apr 2, 2025. Source: company's own press page. source ↗

Raised: $9.0M. Last 2 years.

Oct 1, 2026 Private equity round: $9M (total, as published), announced Oct 1, 2026. Source: company's own press page. source ↗
Sep 2, 2025 Partnership / licensing announced Sep 2, 2025. Source: company's own press page. source ↗
Apr 2, 2025 Partnership / licensing announced Apr 2, 2025. Source: company's own press page. source ↗